ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,354.17
0.49%
Dow Jones
38,980.64
0.25%
Gold vs US Dollar
2,315.11
0.00%
Brent Oil
83.34
0.57%
Bitcoin
62,011.01
-0.52%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Qiagen NV (QGEN)

  7. Qiagen NV (QGEN) News

Qiagen NV (QGEN)

Qiagen NV
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:QGEN
DateTimeSourceHeadlineSymbolCompany
07/05/202421:05GlobeNewswire Inc.QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensicsNYSE:QGENQiagen NV
02/05/202421:05GlobeNewswire Inc.QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inherited disease applicationsNYSE:QGENQiagen NV
29/04/202421:05GlobeNewswire Inc.QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidanceNYSE:QGENQiagen NV
24/04/202421:05GlobeNewswire Inc.QIAGEN expands tuberculosis portfolio with new NGS Panel to support real-time surveillance and combat antimicrobial resistanceNYSE:QGENQiagen NV
09/04/202414:48GlobeNewswire Inc.QIAGEN N.V. to release results for Q1 2024 and hold webcastNYSE:QGENQiagen NV
03/04/202421:05GlobeNewswire Inc.QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024NYSE:QGENQiagen NV
25/03/202420:05GlobeNewswire Inc.QIAGEN introduces QIAstat-Dx Analyzer 2.0 with remote test results access, enhancing collaboration across healthcare systemNYSE:QGENQiagen NV
18/03/202420:05GlobeNewswire Inc.QIAGEN partners with International Panel Physicians Association to increase awareness of tuberculosis screening requirementsNYSE:QGENQiagen NV
11/03/202409:59GlobeNewswire Inc.QIAGEN announces Form 20-F annual report filing for 2023 resultsNYSE:QGENQiagen NV
27/02/202422:44GlobeNewswire Inc.QIAGEN launches AI-derived biomedical knowledge base to accelerate data-driven drug discoveryNYSE:QGENQiagen NV
27/02/202421:05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
15/02/202421:05GlobeNewswire Inc.QIAGEN earns ACT Label for new eco-friendlier QIAwave products and achieves first My Green Lab Platinum certificationNYSE:QGENQiagen NV
08/02/202414:47Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
06/02/202421:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q4 2023, led by 8% CER sales growth in non-COVID products and improved operational profitabilityNYSE:QGENQiagen NV
25/01/202415:00GlobeNewswire Inc.QIAGEN announces partnership with Penn State University to advance microbiome sciencesNYSE:QGENQiagen NV
23/01/202421:13Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NYSE:QGENQiagen NV
18/01/202421:05GlobeNewswire Inc.QIAGEN announces details for completion of synthetic share repurchase of up to approximately $300 millionNYSE:QGENQiagen NV
11/01/202412:53GlobeNewswire Inc.QIAGEN N.V. to release results for Q4 2023 and hold webcastNYSE:QGENQiagen NV
08/01/202414:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:QGENQiagen NV
08/01/202407:00GlobeNewswire Inc.QIAGEN receives FDA clearance of NeuMoDx CT/NG Assay for use on both NeuMoDx 96 and 288 Molecular SystemsNYSE:QGENQiagen NV
07/01/202418:07GlobeNewswire Inc.QIAGEN announces plans to return approximately $300 million to shareholdersNYSE:QGENQiagen NV
04/01/202421:05GlobeNewswire Inc.QIAGEN to accelerate investments into QIAGEN Digital Insights bioinformatics businessNYSE:QGENQiagen NV
03/01/202407:00GlobeNewswire Inc.QIAGEN expands business in Middle East with new regional headquarters and major projectsNYSE:QGENQiagen NV
30/11/202321:05GlobeNewswire Inc.DNA Labs International solves significant cold cases with QIAGEN workflow for forensic genetic genealogyNYSE:QGENQiagen NV
15/11/202321:05GlobeNewswire Inc.QIAGEN launches TissueLyser III and RNeasy PowerMax Soil Pro Kit for improved sample processing and RNA isolationNYSE:QGENQiagen NV
09/11/202321:05GlobeNewswire Inc.QIAGEN launches new QIAcuity digital PCR kits and updated software to expand use by biopharma and food safety customersNYSE:QGENQiagen NV
06/11/202321:05GlobeNewswire Inc.QIAGEN launches complete Sample to Insight workflow for microbiome researchNYSE:QGENQiagen NV
02/11/202312:00PR Newswire (US)QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
02/11/202312:00GlobeNewswire Inc.QIAGEN and Element Biosciences partner to offer complete next-generation sequencing workflows for the AVITI SystemNYSE:QGENQiagen NV
30/10/202320:05GlobeNewswire Inc.QIAGEN exceeds outlook for Q3 2023 with 5% CER sales growth in non-COVID products and adjusted EPS of $0.50 CERNYSE:QGENQiagen NV
 Showing the most relevant articles for your search:NYSE:QGEN

Your Recent History

LSE
BOO
Boohoo
LSE
POS
Plexus
LSE
CHLL
Chill Brands
LSE
AAZ
Anglo Asian Mining
LSE
RR.
Rolls-royce
LSE
VAST
Vast Resources
LSE
CSFS
Cornerstone Fs
LSE
AGL
Angle
LSE
BARC
Barclays
LSE
APH
Alliance Pharma
LSE
PET
Petrel Resources
LSE
TERN
Tern
LSE
GKP
Gulf Keystone Petroleum
LSE
SYME
Supply@me Capital
LSE
SCLP
Scancell
LSE
AAU
Ariana Resources
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved